Divergent regulatory T cell responses to high-dose methylprednisolone and tocilizumab in giant cell arteritis.

Scholz, Godehard A; Fux, Michaela; Christ, Lisa; Iype, Joseena; Banz, Yara; Villiger, Peter M (2022). Divergent regulatory T cell responses to high-dose methylprednisolone and tocilizumab in giant cell arteritis. Journal of autoimmunity, 133, p. 102909. Elsevier 10.1016/j.jaut.2022.102909

[img]
Preview
 Text
1-s2.0-S0896841122001172-main.pdf - Published Version
Available under License Creative Commons: Attribution (CC-BY).
Download (2MB) | Preview

Item Type:

 Journal Article (Original Article)

Division/Institute:

 04 Faculty of Medicine > Department of Haematology, Oncology, Infectious Diseases, Laboratory Medicine and Hospital Pharmacy (DOLS) > Institute of Clinical Chemistry
04 Faculty of Medicine > Department of Dermatology, Urology, Rheumatology, Nephrology, Osteoporosis (DURN) > Clinic of Rheumatology, Clinical Immunology and Allergology
04 Faculty of Medicine > Pre-clinic Human Medicine > Institute of Social and Preventive Medicine (ISPM)
04 Faculty of Medicine > Service Sector > Institute of Pathology

UniBE Contributor:

 Scholz, Godehard Albert, Fux, Michaela, Christ, Lisa Alexandra, Iype, Joseena Mariam, Banz Wälti, Yara Sarah, Villiger, Peter Matthias

Subjects:

 600 Technology > 610 Medicine & health
500 Science > 570 Life sciences; biology
300 Social sciences, sociology & anthropology > 360 Social problems & social services

ISSN:

 0896-8411

Publisher:

 Elsevier

Language:

 English

Submitter:

 Pubmed Import

Date Deposited:

 22 Sep 2022 09:30

Last Modified:

 05 Dec 2022 16:24

Publisher DOI:

 10.1016/j.jaut.2022.102909

PubMed ID:

 36115211

Uncontrolled Keywords:

 CD15s FOXP3 EXON2 Giant cell arteritis Methylprednisolone Regulatory T cells Tocilizumab

BORIS DOI:

 10.48350/173030

URI:

 https://boris.unibe.ch/id/eprint/173030

Actions (login required)

Edit item Edit item
Provide Feedback